Nutralytica Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-04-2024
- Paid Up Capital ₹ 0.10 M
as on 23-04-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Revenue 23.31%
(FY 2021)
- Profit 164.03%
(FY 2021)
- Ebitda 242.29%
(FY 2021)
- Net Worth 49.19%
(FY 2021)
- Total Assets 9.80%
(FY 2021)
About Nutralytica Research
- CIN/LLPIN
U74120MH2014PTC258965
- Company No.
258965
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nutralytica Research Private Limited offer?
Nutralytica Research Private Limited offers a wide range of products and services, including Diagnostic Imaging & Pathology Labs, Medical Test Services.
Who are the key members and board of directors at Nutralytica Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Kelkar  | Managing Director | 29-Oct-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subhash Kelkar | Director | 29-Oct-2014 | Current |
Financial Performance of Nutralytica Research.
Nutralytica Research Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 23.31% increase. The company also saw a substantial improvement in profitability, with a 164.03% increase in profit. The company's net worth Soared by an impressive increase of 49.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutralytica Research?
In 2021, Nutralytica Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hexagon Nutrition (Exports) Private LimitedActive 12 years 5 monthsSubhash Kelkar and Aditya Kelkar are mutual person
- Hexagon Nutrition (International) Private LimitedActive 11 years 11 months
Subhash Kelkar and Aditya Kelkar are mutual person
- Hexagon Nutrition LimitedActive 31 years 6 months
Subhash Kelkar and Aditya Kelkar are mutual person
- Sunrise Nutrition Private LimitedActive 13 years 5 months
Subhash Kelkar and Aditya Kelkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nutralytica Research?
Nutralytica Research has a workforce of 25 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutralytica Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutralytica Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
